Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 517.10K | 513.90K | 418.20K | 507.90K | 569.40K |
| Total Other Revenue | 204.30K | 204.30K | 204.30K | 0.00 | 434.30K |
| Total Revenue | 721.40K | 718.20K | 622.50K | 507.90K | 1.00M |
| Cost of Revenue | 407.80K | 394.60K | 222.40K | 335.10K | 606.20K |
| Gross Profit | 313.60K | 323.60K | 400.10K | 172.90K | 397.50K |
| SG&A Expenses | 9.74M | 10.98M | 11.44M | 15.66M | 18.62M |
| Depreciation & Amortization | 992.20K | 1.08M | 1.11M | 1.20M | 1.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.80M | 32.66M | 31.91M | 36.04M | 39.76M |
| Operating Income | -30.08M | -31.94M | -31.28M | -35.53M | -38.75M |
| Income Before Tax | -48.68M | -50.13M | -48.51M | -33.33M | -35.95M |
| Income Tax Expenses | -1.62M | -1.63M | -1.62M | -1.15M | 38.30K |
| Earnings from Continuing Operations | -47.06 | -48.50 | -46.90 | -32.18 | -35.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.06M | -48.50M | -46.90M | -32.18M | -35.99M |
| EBIT | -30.08M | -31.94M | -31.28M | -35.53M | -38.75M |
| EBITDA | -29.09M | -30.86M | -30.18M | -34.33M | -37.47M |
| EPS Basic | -23.84 | -29.39 | -32.38 | -29.44 | -34.31 |
| Normalized Basic EPS | -9.40 | -13.06 | -15.50 | -20.24 | -22.87 |
| EPS Diluted | -23.99 | -29.53 | -32.52 | -29.64 | -34.44 |
| Normalized Diluted EPS | -9.40 | -13.06 | -15.50 | -20.24 | -22.87 |
| Average Basic Shares Outstanding | 9.71M | 6.50M | 5.32M | 4.46M | 4.22M |
| Average Diluted Shares Outstanding | 9.71M | 6.50M | 5.32M | 4.46M | 4.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |